C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof

Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273)
11/1999
11/16/1999	US5985292 Active phospholipids as a vector for active molecules
11/16/1999	US5985241 Diagnostic and radiodiagnostic agents, formed by reacting technetium-99m with a somatostatin receptor-binding peptide
11/16/1999	US5985240 Labeling somatostatin-derived peptides with perrhenate, treating rheumatoid arthritis,
11/16/1999	CA1340824C Neurokinin a antagonists
11/11/1999	WO1999057305A1 Method for screening for substances which are activators or inhibitors of protein kinase b
11/11/1999	WO1999057281A2 Peptide antibiotics which inhibit the growth of pneumococci, abc transporter and two-component signal transduction system proteins from streptococcus pneumoniae, and methods using the same
11/11/1999	WO1999057276A1 Multifunctional adhesin proteins and their display in microbial cells
11/11/1999	WO1999057272A1 Peptide inhibitors of hiv replication
11/11/1999	WO1999057262A2 Peptide binding to metal ions
11/11/1999	WO1999057157A1 Laundry detergent and/or fabric care compositions comprising a modified antimicrobial protein
11/11/1999	WO1999057155A1 Laundry detergent and/or fabric care compositions comprising a modified antimicrobial protein
11/11/1999	WO1999057138A1 Compositions comprising a peptide inhibitor of nuclear protein translocation and an immunosuppresssant and methods of use thereof
11/11/1999	WO1999056766A2 Method for treating ischemia
11/11/1999	WO1999056760A1 N1-modified glycopeptides
11/11/1999	WO1999041608A3 Interaction between cyclin d1 and steroid receptor co-activators
11/11/1999	DE19819843A1 Metallchelat bindende Peptide Metal chelate binding peptides
11/11/1999	CA2331139A1 Laundry detergent and/or fabric care compositions comprising a modified antimicrobial protein
11/11/1999	CA2330699A1 Multifunctional adhesin proteins and their display in microbial cells
11/11/1999	CA2330619A1 N1-modified glycopeptides
11/11/1999	CA2327540A1 Method for screening for substances which are activators or inhibitors of protein kinase b
11/11/1999	CA2325387A1 Method for treating ischemia
11/10/1999	EP0955312A2 Antimicrobial peptide
11/10/1999	EP0955311A2 Peptide vaccine for canine allergy
11/10/1999	EP0955309A1 Inhibitors and substrates of thrombin
11/10/1999	EP0955308A1 Process for one-step re-salting and purification of peptides
11/10/1999	EP0955055A2 FGF inhibitor, angiogenesis inhibitor and antitumor agent containing complestatin or its derivative as effective ingredient
11/10/1999	EP0954585A2 Human telomerase catalytic subunit
11/10/1999	EP0954531A1 aPL IMMUNOREACTIVE PEPTIDES, CONJUGATES THEREOF AND METHODS OF TREATMENT FOR aPL ANTIBODY-MEDIATED PATHOLOGIES
11/10/1999	EP0954530A1 Immunomodulatory peptides of vespid antigen 5
11/10/1999	EP0584256B1 Compounds and pharmaceutical compositions for detecting and localizing tissues having neurokinine 1 receptors
11/09/1999	US5981711 Antibodies which bind to protein from putative oncogene; for probes and imaging agents used in diagnosis/prognosis of cancer/tumors; anticarcinogenic/antitumor agents and vaccines
11/09/1999	US5981698 Antimicrobial polypeptides
11/09/1999	US5981697 Synthetic peptides, antibodies against them and their use
11/09/1999	US5981479 Administering to the aids patient a nonimmunosuppressive, cyclophilin-bining cyclosporin which binds to human genetic engineered cyclophilin and has an activity in the mixed lymphocyte reaction of not more than 10% that of ciclosporin
11/09/1999	US5981478 Integrin-binding peptides
11/09/1999	US5981477 Peptide-metal chelate conjugates
11/09/1999	US5981299 Method of producing antibodies to an enzyme; immunizing cows with purified enzymes, recovering milk from cows, purifying antibodies; to alter the cholesterol composition of food; dietetics
11/09/1999	US5981264 Peptides from pseudomonas syringae possessing broad-spectrum antibiotic activity
11/09/1999	US5981170 Diagnostic immunoassay kit for detection of antibodies induced by human immunodeficiency virus in sample of body fluid; includes artificial peptide of an epitope having a cystine bridge
11/09/1999	US5980913 A tetrapeptides as vaccine adjuvant
11/09/1999	US5980899 Identification of peptides that stimulate hepatitis C virus specific cytotoxic T cells
11/06/1999	CA2270847A1 Alpha-ketoamide derivatives
11/04/1999	WO1999055727A1 A process for the conversion of echinocandin class of peptides to their c4-homotyrosine monodeoxy analogues
11/04/1999	WO1999055358A1 Methods for treating hot flashes and gynaecomastia
11/04/1999	CA2329941A1 Methods for treating hot flashes and gynaecomastia
11/04/1999	CA2327474A1 A process for the conversion of echinocandin class of peptides to their c4-homotyrosine monodeoxy analogues
11/03/1999	EP0953835A1 Apparatus for detection of a fluorescence pattern corresponding to ligand binding on a substrate
11/03/1999	EP0953646A2 Herbicide tolerant transgenic plants where the herbicide inhibits prophyrin biosynthesis
11/03/1999	EP0953573A2 Pentapeptide with specific conformation, its production and use
11/03/1999	EP0953572A2 Peptides binding to bone marrow stromal cell antigen
11/03/1999	EP0952986A1 Antimicrobially active polypeptides
11/03/1999	EP0952982A2 Novel hepatitis b inhibitors
11/03/1999	EP0853484A4 Novel mu opioid receptor ligands: agonists and antagonists
11/03/1999	EP0737073A4 Novel peptides for heparin and low molecular weight heparin anticoagulation reversal
11/03/1999	EP0655069B1 Amphiphilic compounds derived from amino acids or peptides, their methods of synthesis and their application as drug delivery systems
11/02/1999	US5977302 Liquid phase process for the preparation of GnRH peptides
11/02/1999	US5977301 Synthesis of N-substituted oligomers
11/02/1999	US5977300 Isolated nonapeptide which bind to HLA-B44 molecules and the uses thereof
11/02/1999	US5977296 Chiral peptide nucleic acid monomers and oligomers
11/02/1999	US5977178 Compounds with growth hormone releasing properties
11/02/1999	US5977084 Self-assembling polynucleotide delivery method
11/02/1999	US5977067 Cyclosporin derivatives, their preparation and the pharmaceutical compositions which contain them
11/02/1999	US5977065 Bacterial nitroreductase for the reduction of CB1954 and analogues thereof to a cytotoxic form
11/02/1999	US5976852 Isolated nucleic acid molecule encoding a receptor protein; for identifying agonists and antagonists; treatment of paralytic disease; antitumor/antimetastasis agents
11/02/1999	US5976785 Competitive assays for determining the effectiveness of a human immunodeficiency virus type 2 (HIV-2) antiviral agent, employing peptides and proteins of HIV-2
11/02/1999	US5976544 Polypeptides and vaccines for Bordetellapertussis and method of use
11/02/1999	US5976494 Technetium-99m labeled peptides for imaging
11/02/1999	US5976381 Chromatographic purification of cyclosporing using a high pressure carbon dioxide eluent
10/1999
10/30/1999	CA2775100A1 Method for giving resistance to weed control compounds to plants
10/28/1999	WO1999054728A2 Method of predicting receptor modulating activity
10/28/1999	WO1999053938A1 Isolated peptides corresponding to amino acid sequences of ny-eso-1, wherein bind to mhc class i and mhc class ii molecules, and uses thereof
10/28/1999	WO1999040112A9 Neuroprotective peptides and uses thereof
10/28/1999	CA2269103A1 Peptides binding to bone marrow stromal cell antigen
10/27/1999	EP0951532A1 Bivalent agonists for g-protein coupled receptors
10/27/1999	EP0951474A1 Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them
10/27/1999	EP0951473A1 Cyclosporin derivative, its preparation and pharmaceutical compositions containing same
10/27/1999	EP0951472A1 Peptide compositions with growth factor-like activity
10/27/1999	EP0167575B2 Cardiodilatine, a peptide hormone and production process thereof
10/27/1999	CN1233288A GnRH-leukotoxin chimeras
10/27/1999	CN1233257A Polypeptide transition metal salts and method of enhancing anti-HIV activity of polypeptide
10/26/1999	US5972895 Peptide consisting of the formula a1-d2methyltrp-ala-trp-dphe-lys wherein a1 is glutamine (gln) or glutamic acid (glu), and organic or inorganic pharmaceutically acceptable salts thereof
10/26/1999	US5972894 Peptides having potassium channel opener activity
10/26/1999	US5972891 A mixture comprising an active nonapeptide or decapeptide and a biodegradable polymer having a terminal carboxyl group, showing constant release of the peptide over a long time
10/26/1999	US5972353 Immunogenic amount of an immunologically active mn protein or m polypeptide effective to immunize a vertebrate against a neoplastic disease associated with expression of mn antigen
10/26/1999	US5972349 Synthesis of polyribosylribitol phosphate oligosaccharides
10/26/1999	US5972308 Reacting technetium-99 with a cyclic oligopeptide having amino acid units containing a mercaptan group attached to the ring through a homocysteine unit.
10/26/1999	CA2029678C Isolation and structural elucidation of the cytostatic linear depsipeptide dolastatin 14
10/21/1999	WO1999052933A1 Process for the preparation of resin-bound cyclic peptides
10/21/1999	WO1999052540A1 Methods for treatment and prevention of infections
10/21/1999	WO1999052539A1 Neo-tryptophan
10/21/1999	WO1999042118A8 Compounds and methods for diagnosis of tuberculosis
10/21/1999	CA2325572A1 Process for the preparation of resin-bound cyclic peptides
10/21/1999	CA2324988A1 Methods for treatment and prevention of infections
10/20/1999	EP0950708A2 Enhanced affinity hyaluronan binding peptides
10/20/1999	EP0950666A1 Diagnostic and Therapy of diseases linked with HHV-8 infection with antibody against Kaposin or with Kaposin-derivated-peptides
10/20/1999	EP0949902A2 Cosmetic preparation with a peptide addition
10/19/1999	US5969126 GNRH-leukotoxin chimeras
10/19/1999	US5968904 Modified arginine containing lytic peptides and method of making the same by glyoxylation
10/19/1999	US5968898 THF-γ2 analogs and pharmaceutical compositions comprising them
10/19/1999	US5968753 Peptides which displace a monoclonal antibody bound to a cell surface antigen on a target cell; for separating specific cells like cd34 positive hematopoeitic stem cells from a heterogeneous cell population

1 ... 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 ... 423